Article
hlamydial infections are the most common bacterial STD in the United States, with an estimated annual incidence of 4 million cases and costs in excess of $2 billion. Pelvic inflammatory disease (PID) (i.e., acute salpingitis) is frequently a consequence of sexually transmitted diseases, including gonococcal, mycoplasmal, and chlamydial infection, and is usually the result of progression of disease from the lower to the upper reproductive tract. Approximately million women are treated for PID in the United States annually, and one-quarter of these women are affected with serious sequelae, including ectopic pregnancy and tubal infertility.
As many as half of these PID cases are caused by chlamydiae. Such infections are now recognized as a major public health problem. However, a limited understanding of the immuno-pathogenesis of PID still exists. This has been due in part to the limited number of clinical specimens available for study and the continued need to develop appropriate and suitable animal models in which to study Ch/amydia trachomatis in particular. [1] [2] [3] [4] 
